Vogt–Koyanagi–Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection - 16/08/11
Doi : 10.1016/j.jinf.2005.05.005
Konstantinos Papastathopoulos a, Evridiki Bouzas a, George Naoum a, Ioannis Vergados b, Sotirios Tsiodras c, ⁎ 
a Medical Retina Unit, First Department of Ophthalmology, Henry Dunant Hospital, 107 Mesogion Avenue, 11526 Athens, Greece
b Academic Department of Ophthalmology, Athens University Medical School, Athens, Greece
c Fourth Department of Internal Medicine, Athens University Medical School, University General Hospital ‘Attikon’, 1 Rimini Street, Xaidari, 12462 Athens, Greece
Corresponding author. Tel.: +30 210 2824581/6932665820; fax: +30 210 6972905.Summary |
A rare case of Vogt–Koyanagi–Harada disease associated with ribavirin and interferon-alpha treatment for chronic hepatitis C infection is presented. The potential role of interferon and/or ribavirin therapy is discussed. Physicians should be aware of the association between interferon-alpha and ribavirin use for hepatitis C infection and the development of Harada’s disease. Close monitoring of such patients for ocular side effects is necessary.
Le texte complet de cet article est disponible en PDF.Keywords : Harada’s, Hepatitis C, Interferon alpha, Ribavirin, Retinal, Side effects
Plan
© 2005
The British Infection Society. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 52 - N° 2
P. e59-e61 - février 2006 Retour au numéro
Article précédent
- Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation
- C. Bachmeyer, G. Mouchnino, P. Thulliez, L. Blum
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?